10-KPeriod: FY1995

BECTON DICKINSON & CO Annual Report, Year Ended Sep 30, 1995

Filed December 27, 1995For Securities:BDX

Summary

BECTON DICKINSON & CO (BDX) filed its 1995 Annual Report (10-K) on December 27, 1995, covering the period ending September 29, 1995. This filing provides a snapshot of the company's financial health and operational performance for the fiscal year. While specific financial figures and detailed operational discussions are not present in the provided snippet, the filing itself signifies BD's commitment to transparent reporting for its investors. Investors should look to the full 10-K document for crucial details on revenue, profitability, cash flows, balance sheet strength, and management's outlook. Key areas of focus for investors would typically include revenue growth across its various business segments, profitability margins, debt levels, and any significant capital expenditures or strategic initiatives undertaken during the year. The nature of BDX's business in medical technology and devices suggests a focus on innovation, regulatory compliance, and market penetration as drivers of performance.

Key Highlights

  • 1BDX filed its 1995 10-K annual report on December 27, 1995.
  • 2The reporting period concluded on September 29, 1995.
  • 3The filing is a standard disclosure for publicly traded companies to provide investors with financial and operational information.
  • 4This report covers BD's performance for the fiscal year 1995.
  • 5Investors can find detailed financial statements, management discussion and analysis (MD&A), and risk factors within the full report.
  • 6The document is a key resource for understanding the company's financial position and strategic direction at that time.

Frequently Asked Questions

The primary purpose of this 10-K filing is to provide investors with a comprehensive overview of Becton Dickinson's financial performance and operational status for the fiscal year ending September 29, 1995. It includes audited financial statements, management's discussion and analysis of financial condition and results of operations, and other important disclosures.

The provided text is a directory listing from the SEC EDGAR database and does not contain the specific financial results. Investors need to access the full 10-K document, likely available through the SEC's EDGAR database or BDX's investor relations website, to find detailed financial statements (income statement, balance sheet, cash flow statement) and management's commentary on performance.

Investors should look for key financial metrics such as revenue, net income, earnings per share, operating margins, debt levels, and cash flow. Additionally, the Management Discussion and Analysis (MD&A) section will offer insights into the factors driving the company's performance, any significant events, and management's outlook for the future. It's also important to review any risk factors disclosed by the company.